错误:患者iPSC中的基因组编辑纠正了最常见的USH2A突变并揭示了引人入胜的突变mRNA表达特征
Molecular therapy. Methods & clinical development
|December 11, 2025
概括
这项研究纠正了先前发表的一篇文章DOI. 更多细节可通过所提供的DOI作为参考提供.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 以前的出版物需要更正.
- 确保科学准确性对于研究完整性至关重要.
研究的目的:
- 为特定的文章提供纠正.
- 为了保持准确的科学记录.
主要方法:
- 修正涉及到数字物体识别符 (DOI).
- 修正后的国标标识是10.1016/j.omtm.2019.11.016.2019.11.016. 时间.
主要成果:
- 文章DOI已经更新.
- 修正后的DOI确保了正确的引用和访问.
结论:
- 科学记录现在是准确的.
- 研究人员现在可以使用正确的DOI引用文章.
相关概念视频
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K


